Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7200
-0.0050 (-0.69%)
Sep 18, 2026, 4:08 PM HKT

HKG:0460 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
301.8179.7-216.66-54.02-1,915416.51
Depreciation & Amortization
187.36189.08228.34211.88338.77278.97
Other Amortization
36.2136.2130.0914.3531.0330.4
Loss (Gain) From Sale of Assets
-168.5-17.19-5.22-7.38-200.07-56.82
Asset Writedown & Restructuring Costs
----1,338131.3
Loss (Gain) From Sale of Investments
-33.91-31.43-27.11-153.02279.36-8.44
Loss (Gain) on Equity Investments
-71.7-11.6115.2353.6280.88158.58
Stock-Based Compensation
9.529.03418.0289.0889.6759.35
Provision & Write-off of Bad Debts
56.0551.956.35-7.9528.4436.51
Other Operating Activities
150.45150.21-191.62-58.19-206.31-124.57
Change in Accounts Receivable
-696.95-690.78-268.55265.79-163.68-245.24
Change in Inventory
-86.37-195.48130.7837.74-60.44-226.81
Change in Accounts Payable
255.04315.9928.49-198.81415.54195.75
Change in Unearned Revenue
40.57-9.24128.016.38-46.0329.77
Operating Cash Flow
-20.45-23.56276.14199.4946.49665.29
Operating Cash Flow Growth
--38.43%329.07%-93.01%192.91%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-78.29-58.35-70.71-125.35-402.46-601.02
Sale of Property, Plant & Equipment
1.981.73.7115.5414.353.13
Cash Acquisitions
6.196.19----153.38
Divestitures
22.1913.8-14.9388.45-
Sale (Purchase) of Intangibles
-156.16-136.15-109.07-170.04-187.49-124.57
Sale (Purchase) of Real Estate
39.639.615.77-1.3--
Investment in Securities
-142.81-380.22562.17246.63-1,190151.15
Other Investing Activities
-81.72155.75285.65224.6538.22376.39
Investing Cash Flow
-392.61-296.48758.24169.88-1,661-337.57

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-272.41318.25385.59480.32836.08
Long-Term Debt Repaid
--279.94-649.98-416.97-328.05-545.63
Lease Payments
-2.4-1.99-8.1-16.45-12.62-3.19
Net Debt Issued (Repaid)
-72.45-7.53-331.73-31.38152.27290.46
Issuance of Common Stock
-----2.74
Repurchase of Common Stock
-152.2-188.63-20.3-33.81--206.41
Common Dividends Paid
-189.36-90.89-177.08-298.56-130.62-122.89
Other Financing Activities
633.1645.2-761.55-55.81924.32786.76
Financing Cash Flow
219.09358.16-1,291-419.56-238.93750.66

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-193.9638.12-256.28-50.2-1,8541,078

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-98.74-81.91205.4474.14-355.9764.28
Free Cash Flow Growth
--177.09%---
Free Cash Flow Margin
-3.75%-3.13%10.81%3.98%-16.32%2.11%
Free Cash Flow Per Share
-0.01-0.010.020.01-0.040.01
Levered Free Cash Flow
-559.91-197.19-838.631,458-532.22-242.96
Unlevered Free Cash Flow
-456.2-71.2-666.791,626-400.23-169.61
Free Cash Flow After Leases
-101.14-83.9197.3457.69-368.5961.09

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
45.3348.1643.4653.9855.6827.93
Cash Income Tax Paid
254.8184.5588.9283.8156.98203.53
Change in Working Capital
-487.71-579.518.74111.1145.4-246.53